CYCLOPHARM LIMITED — Director's Dealing 2007

Feb 11, 2007

Rule 3.19A.1

Appendix 3X

Initial Director's Interest Notice

	Name of entity CYCLOPHARM LIMITED
ABN	74 116 931 250

We (the entity) give ASX the following information under listing rule 3.19A.1 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Henry George Townsing
Date of appointment	22/11/2005

Part 1 - Director's relevant interests in securities of which the director is the registered holder

Number & class of securities Ordinary Shares	Nil
Direct:	Nil

$\overline{\text{+ See chapter 19}}$ for defined terms.

Part 2 – Director's relevant interests in securities of which the director is not the registered holder

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interest	Number & class of Securities
Normandy Finance & Investments Asia Limited (Director)	Ordinary Shares	6,512,057
Glen Nominees Ltd (Nominee for Normandy Finance & Investments Asia Limited)	Ordinary Shares	1,012,199
Normandy Nominees Limited (Nominee for Normandy Finance & Investments Asia Limited)	Ordinary Shares	4,912,107
Pilmora Pty Ltd (Director)	Ordinary Shares	853,980
Brent Townsing (child)	Ordinary Shares	10,000
Edward Townsing (child)	Ordinary Shares	15,000
Gaynor Townsing (spouse)	Ordinary Shares	12,590
Henry Townsing (father's estate)	Ordinary Shares	22,000
Henry Townsing (child)	Ordinary Shares	20,000
Lloyd Townsing (child)	Ordinary Shares	15,000
Indirect		13,384,933
Total (Direct & Indirect):		13,384,933

Part 3 – Director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract	Nil
Nature of interest
Name of registered holder (if issued securities)
No. and class of securities to which interest relates

$\overline{\text{+ See chapter 19}}$ for defined terms.